Funded Startups in Tartumaa
Across the 18 most recent funded entries in Tartumaa, the largest disclosed round is Gren’s $1.3B (2026-05-05), a scale far above the rest of the disclosed…
Across the 18 most recent funded entries in Tartumaa, the largest disclosed round is Gren’s $1.3B (2026-05-05), a scale far above the rest of the disclosed amounts in this slice, where the next-highest visible figures include Icosagen Group’s $19M (2023-02-08) and Antegenes’ $2M (2022-08-02) and Remato’s $2M (2021-08-11). On the low end, the smallest disclosed amount shown is Decomer Technology’s $100K (2022-04-11).
The list also clusters by time: eight entries fall between 2024-08-09 (Viacurrent) and 2026-05-05 (Gren), with multiple April 2026 biotechnology rounds that are marked undisclosed (Chemestmed and Vectiopep, both on 2026-04-23). Sector-wise, biotechnology appears frequently (5 entries: Chemestmed, Vectiopep, Gearbox Biosciences, Icosagen Group, Antegenes, plus Decomer Technology is also biotechnology—making 6 total in the rows shown), while stage disclosure is uneven: 7 rows are either “undisclosed” or “Series Unknown.” The visible window runs from 2021-05-18 (LightCode Photonics) through 2026-05-05 (Gren).
Most recent rounds
18 shownRelated listings
Frequently asked
What’s the largest disclosed round in Tartumaa here, and how much does it dominate the rest?
Gren’s $1.3B (2026-05-05) is the only disclosed amount above the $100M level and is far beyond the next-largest disclosed figure shown, Icosagen Group’s $19M (2023-02-08). The rest of the disclosed rounds are comparatively concentrated in the low single-digit millions and below (for example, Solid World DAO $3M on 2022-05-03 and Antegenes/Remato at $2M in 2022-08-02 and 2021-08-11).
Are there temporal clusters in the most recent rounds?
Yes. Eight of the 18 entries date between 2024-08-09 (Viacurrent) and 2026-05-05 (Gren), including two April 2026 events on 2026-04-23: Chemestmed (biotechnology) and Vectiopep (biotechnology), both marked undisclosed. A second cluster appears in 2022, with multiple biotech/other rounds spanning 2022-04-11 through 2022-08-02.
Which sectors look most concentrated across these 18 rows?
Biotechnology is the most represented sector, appearing in 6 entries: Chemestmed (2026-04-23, undisclosed), Vectiopep (2026-04-23, undisclosed), Gearbox Biosciences ($400K on 2023-10-13), Icosagen Group ($19M on 2023-02-08), Antegenes ($2M on 2022-08-02), and Decomer Technology ($100K on 2022-04-11). Health Care shows up once (Better Medicine, $1M on 2025-08-14).
How complete is disclosed funding vs. undisclosed/unknown amounts and stages?
Funding amounts are undisclosed in 2 rows (Chemestmed and Vectiopep, both on 2026-04-23), and stage labels are frequently not detailed: “Series Unknown” appears for 7 rows and one row has a blank stage (Introwise on 2021-05-25). This means both amount and stage visibility vary substantially around the mid-2020s entries.
Who are the outliers on the low end, and do they align with any sector pattern?
The smallest disclosed round is Decomer Technology at $100K (2022-04-11), which is notably lower than nearby disclosed biotech rounds like Gearbox Biosciences’ $400K (2023-10-13) and Icosagen Group’s $19M (2023-02-08). Another relatively low disclosed entry is Better Medicine is not low ($1M on 2025-08-14), while most sub-$1M disclosed amounts are concentrated around biotech and early-stage labels (e.g., Decomer Technology pre-seed, Gearbox Biosciences pre-seed).
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.